Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 632
Selected: 0
NCT IDTitle
NCT04140552Chinese Research Group of Gallbladder Cancer
NCT07019233A Study of the Effect of Real-time Pressure Controllers on Subjective and Objective Symptoms of Peripheral Neuropathy Induced by Albumin Paclitaxel
NCT07778732Adebrelimab Combined With Dalpiciclib Isethionate Plus Chemotherapy for Neoadjuvant Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT05720533Disitamab Vedotin Combined With Sintilimab as First-line Treatment of Elderly Patients With Gastric Cancer
NCT06852287Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
NCT04970264A Multicenter, Open and Observational Real World Study on the Prognosis and Treatment in Young Women With Breast Cancer
NCT07658105Eparlitozoviril as Adjuvant Therapy for Resectable HCC With MVI
NCT01634984The Diagnostic Technology Applied Research of CDK5RAP2 in Breast Cancer
NCT06878625A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer
NCT07729033A Phase II Exploratory Study of Sacituzumab Tirumotecan Combined With Envafolimab for TROP2-Positive Advanced Biliary Tract Cancers Previously Treated With First-Line Immunotherapy Combined With Chemotherapy.
NCT06991478SK-NK Injection in Patients With Advanced Solid Tumors Accompanied by Malignant Ascites
NCT07799935IRE After Chemotherapy for Locally Advanced Pancreatic Cancer
NCT05955391TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)
NCT03366883Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC
NCT06836869Modified Tumor-free Techniques Operation to Cervical Cancer
NCT03987698Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma
NCT07799922IRE After Targeted Immunotherapy in HCC With Portal Vein Tumor Thrombus
NCT07828756Albumin-bound Paclitaxel (Ⅱ)-Combined Regimens for Pancreatic Cancer
NCT02765620PERCIST Criteria for Response Evaluation With Solid Tumors
NCT04807673Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)
NCT03121846Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy
NCT05458180CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma
NCT06717022A Clinical Study of CHT102 in Mesothelin Positive Advanced Solid Tumors
NCT07246330Stratified Treatment in Unresectable Locally Advanced ESCC Without Progression After Chemoimmunotherapy Induction Plus CCRT: Toripalimab Consolidation vs observation--a Prospective, Randomized, Controlled Phase III Multicenter Study
NCT07847671Fecal Microbiota Transplantation Combined With QL1706 Plus Bevacizumab for Advanced HCC
NCT05853172Surgical Conversion of Candonilimab (AK104) Plus Paclitaxel, S-1 and Apatinib for Unresectable Advanced G/GEJ Cancer
NCT06484764Validate the Safety and Feasibility of the CT-guided Interventional Robot in Percutaneous Biopsy Procedure.
NCT07475026A Study of Neoadjuvant Tislelizumab Plus Lenvatinib in Resectable HCC at High Risk of Recurrence
NCT04813523Pembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ Adenocarcinoma
NCT07817056Risk-Stratified Management of Inavolisib-Induced Hyperglycemia and Patient Adherence
NCT01216527Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer
NCT07796906Five-Element Music Therapy for Psychological Distress in Pancreatic Cancer Chemotherapy
NCT07063225Romiplostim N01 for Chemotherapy-induced Thrombocytopenia
NCT03299738A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL
NCT05524155Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis
NCT05522985Toripalimab-based Neoadjuvant Therapy in LA-HNSCC
NCT05871099Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
NCT05167643H (Trastuzumab or Biosimilar) Combined With CDK4/6 Inhibitor + AI±OFS in the Treatment of HR+HER2+ Advanced Breast Cancer Efficacy and Safety: a Chinese Multi-center Real World Study
NCT07078292The Efficacy and Safety of First-line Treatment Combined With Immunotherapy for Advanced Hepatocellular Carcinoma: a Single Center, Real-world Study
NCT07840092Biomarker Validation for Treatment Efficacy and Recurrence Prediction in Hepatocellular Carcinoma
NCT05273814Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer
NCT07141186QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy
NCT05863871Real World Study of Linperlisib for Lymphoma Treatment
NCT05035381PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal Cancer
NCT07854977Fecal Microbiota Transplantation Combined With NALIRIFOX Plus Serplulimab as First-line Treatment for Advanced or Metastatic Pancreatic Ductal Adenocarcinoma.
NCT03180177Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer
NCT04850027MRI-guided Lateral Lymph Node Dissection in Rectal Cancer
NCT04908566Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07528274Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure
NCT06828718The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC)